Table 1 Clinical information of 2008 MACS study participants
| Â | ID | Sample Date | Viral Load (copies/ml) | CD4/mm3 |
|---|---|---|---|---|
Group A = HIV-1 Negative N = 10 | XX110 | 8/27/2008 | N/A | 642 |
| Â | XX712 | 8/16/2008 | N/A | 1317 |
| Â | XX163 | 8/19/2008 | N/A | 899 |
| Â | XX983 | 8/19/2008 | N/A | 1153 |
| Â | XX271 | 9/5/2008 | N/A | 828 |
| Â | XX003 | 9/16/2008 | N/A | 547 |
| Â | XX744 | 9/25/2008 | N/A | 1520 |
| Â | XX186 | 9/24/2008 | N/A | 839 |
| Â | XX148 | 9/17/2008 | N/A | 724 |
| Â | XX021 | 8/19/2008 | N/A | 845 |
Group B = HIV-1 Positive/No antiretroviral treatment (ART) N = 11 | XX280 | 8/26/2008 | 1003 | 923 |
| Â | XX495 | 8/16/2008 | 35471 | 238 |
| Â | XX326 | 8/23/2008 | 20149 | 392 |
| Â | XX286 | 9/17/2008 | 2974 | 320 |
| Â | XX119 | 8/26/2008 | 18231 | 301 |
| Â | XX200 | 8/26/2008 | 58200 | 149 |
| Â | XX305 | 9/4/2008 | 582 | 388 |
| Â | XX053 | 9/26/2008 | 78636 | 406 |
| Â | XX109 | 9/25/2008 | 428 | 358 |
| Â | XX013 | 9/12/2008 | 20441 | 457 |
| Â | XX634 | 9/18/2008 | 6779 | 352 |
Group C = HIV -1 Positive/ART/Non-detectable viral load N = 13 | XX484 | 8/19/2008 | <50 | 440 |
| Â | XX008 | 8/20/2008 | <50 | 890 |
| Â | XX523 | 9/5/2008 | <50 | 696 |
| Â | XX245 | 9/23/2008 | <50 | 566 |
| Â | XX163 | 9/10/2008 | <50 | 549 |
| Â | XX690 | 9/9/2008 | <50 | 385 |
| Â | XX005 | 8/28/2008 | <50 | 777 |
| Â | XX144 | 8/28/2008 | <50 | 583 |
| Â | XX154 | 8/20/2008 | <50 | 922 |
| Â | XX327 | 9/30/2008 | <50 | 426 |
| Â | XX350 | 9/3/2008 | <50 | 466 |
| Â | XX263 | 9/17/2008 | <50 | 697 |
| Â | XX265 | 9/25/2008 | <50 | 478 |
Group D = HIV-1 Positive/ART detectable viral load N = 5 | XX127 | 9/3/2008 | 694 | 161 |
| Â | XX229 | 8/28/2008 | 186 | 540 |
| Â | XX371 | 9/10/2008 | 33751 | 152 |
| Â | XX099 | 9/23/2008 | 842 | 153 |
| Â | XX274 | 9/9/2008 | 16842 | 279 |